洞察有效的N-acyl-O-aminophenol二甲胺原药的免费药物释放情况
Nilanjana Chakraborty1, Jelena Momirov1, Aleksandar Radakovic1
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, United States.
ACS chemical biology
|February 10, 2025
概括
新的二甲素前体药物显示出作为向癌症治疗的前景. 这些化合物被癌细胞中的蛋白质选择性地激活,通过持续的药物释放提供潜在的少毒性治疗.
科学领域:
- 药用化学 医学化学
- 药理学 药理学 是一个学科.
- 在瘤学瘤学.
背景情况:
- N-acyl O-aminophenol 前药是一种独特的类别的二甲胺类同类药物.
- 这些前期药物最初预计将在低氧瘤环境中分裂.
- 显著的稳定性表明了另一种释放机制.
研究的目的:
- 研究从N-acyl O-aminophenol前药物中自由释放药物的立体选择机制.
- 了解癌症与正常细胞中的前药1的优先激活.
主要方法:
- 涉及前药物1的研究,一个原型N-acyl O-aminophenol.
- 在脊椎动物瘤模型中进行体内疗效测试.
- 在体外研究比较癌症细胞系和正常人细胞系.
主要成果:
- 与传统化疗药物相比,Prodrug 1在体内有效性显著,毒性降低.
- 自由药物的激活和释放以缓慢,持续的速度在细胞内发生.
- 在癌症细胞系中观察到选择性激活,而不是正常的人类细胞系.
结论:
- 从前药物1中释放的自由药物是由一种蛋白质介导的,可能是基于细胞质囊的酶.
- 这种由蛋白质介导的N-O键裂变是立体选择性的,并且优先发生在癌细胞中.
- 这些发现表明,瘤学可能是一个新的针对性精确疗法.
相关概念视频
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
Factors Influencing Drug Absorption: Drug Dissolution
401
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
401
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
171
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
171
Factors Affecting Dissolution: Particle Size and Effective Surface Area
681
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
681
Factors Influencing Drug Absorption: Pharmaceutical Parameters
113
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
113
Drug Metabolism: Phase II Reactions
3.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.5K


